AXSM

Axsome Therapeutics, Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Tabuteau HerriotDirector, 10 Percent Owner, Officer: Chief Executive Officer
$23M99.3k shares
Grant / ExerciseJun 9, 2026
$12.0M49.7k shares
$241.01
$234.52
Tabuteau HerriotDirector, 10 Percent Owner, Officer: Chief Executive Officer
$1.7M7.2k shares
SellJun 9, 2026
$12.0M49.7k shares
$241.01
$234.52
Pizzie NickChief Financial Officer
$10M42.9k shares
SellJun 9, 2026
$7.9M33k shares
$240.09
$234.52
Tabuteau HerriotDirector, 10 Percent Owner, Officer: Chief Executive Officer
$13M56.9k shares
Grant / ExerciseJun 9, 2026
$245.9K49.7k shares
$4.95
$234.52
Pizzie NickChief Financial Officer
$17M72k shares
Grant / ExerciseJun 9, 2026
$115.5K33k shares
$3.50
$234.52
Jeffs RogerDirector
$404k1.7k shares
Grant / ExerciseJun 5, 2026
Disclosure amount unavailable1.7k shares
--
$234.52

News

seekingalpha.comAxsome Therapeutics, Inc. (AXSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 8marketbeat.comAxsome Therapeutics Readies Auvelity Alzheimer's Agitation Launch, Expands CNS Pipelinemarketbeat.comJun 6globenewswire.comAxsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meetingglobenewswire.comJun 4zacks.comWhy Is Axsome (AXSM) Down 0.4% Since Last Earnings Report?zacks.comJun 3globenewswire.comAxsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigationglobenewswire.comJun 3